1. Home
  2. PLSE vs AORT Comparison

PLSE vs AORT Comparison

Compare PLSE & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • AORT
  • Stock Information
  • Founded
  • PLSE 2014
  • AORT 1984
  • Country
  • PLSE United States
  • AORT United States
  • Employees
  • PLSE N/A
  • AORT N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • AORT Medical/Dental Instruments
  • Sector
  • PLSE Health Care
  • AORT Health Care
  • Exchange
  • PLSE Nasdaq
  • AORT Nasdaq
  • Market Cap
  • PLSE 1.1B
  • AORT 1.4B
  • IPO Year
  • PLSE 2016
  • AORT 1993
  • Fundamental
  • Price
  • PLSE $15.35
  • AORT $31.74
  • Analyst Decision
  • PLSE
  • AORT Strong Buy
  • Analyst Count
  • PLSE 0
  • AORT 5
  • Target Price
  • PLSE N/A
  • AORT $32.40
  • AVG Volume (30 Days)
  • PLSE 199.0K
  • AORT 321.1K
  • Earning Date
  • PLSE 08-11-2025
  • AORT 08-07-2025
  • Dividend Yield
  • PLSE N/A
  • AORT N/A
  • EPS Growth
  • PLSE N/A
  • AORT N/A
  • EPS
  • PLSE N/A
  • AORT N/A
  • Revenue
  • PLSE N/A
  • AORT $390,084,000.00
  • Revenue This Year
  • PLSE N/A
  • AORT $12.18
  • Revenue Next Year
  • PLSE N/A
  • AORT $10.39
  • P/E Ratio
  • PLSE N/A
  • AORT N/A
  • Revenue Growth
  • PLSE N/A
  • AORT 5.94
  • 52 Week Low
  • PLSE $11.13
  • AORT $21.97
  • 52 Week High
  • PLSE $25.00
  • AORT $32.33
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 42.65
  • AORT 61.57
  • Support Level
  • PLSE $14.68
  • AORT $30.44
  • Resistance Level
  • PLSE $15.40
  • AORT $31.66
  • Average True Range (ATR)
  • PLSE 0.61
  • AORT 0.67
  • MACD
  • PLSE -0.00
  • AORT -0.01
  • Stochastic Oscillator
  • PLSE 45.06
  • AORT 73.30

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Share on Social Networks: